Failure of anti-EGFR therapy in p16-positive head and neck cancer.
作者信息
Roesler Rafael, Schwartsmann Gilberto
机构信息
Departments of Pharmacology and Internal Medicine, Federal University of Rio Grande do Sul, Brazil; Cancer Research Laboratory, University Hospital Research Center, Brazil; National Institute for Translational Medicine, 90035-003 Porto Alegre, Rio Grande do Sul, Brazil.
Departments of Pharmacology and Internal Medicine, Federal University of Rio Grande do Sul, Brazil; Cancer Research Laboratory, University Hospital Research Center, Brazil; National Institute for Translational Medicine, 90035-003 Porto Alegre, Rio Grande do Sul, Brazil.
出版信息
Lancet Oncol. 2013 Oct;14(11):e436-e437. doi: 10.1016/S1470-2045(13)70400-5.
Abstract
摘要
相似文献
1
Failure of anti-EGFR therapy in p16-positive head and neck cancer.p16 阳性头颈部癌中抗表皮生长因子受体（EGFR）治疗的失败
Lancet Oncol. 2013 Oct;14(11):e436-e437. doi: 10.1016/S1470-2045(13)70400-5.
2
Failure of anti-EGFR therapy in p16-positive head and neck cancer - authors' reply.p16 阳性头颈癌中抗表皮生长因子受体（EGFR）治疗的失败——作者回复
Lancet Oncol. 2013 Oct;14(11):e437-e438. doi: 10.1016/S1470-2045(13)70289-4.
3
EGFR-directed treatments in SCCHN.头颈部鳞状细胞癌中针对表皮生长因子受体的治疗
Lancet Oncol. 2013 Jul;14(8):672-3. doi: 10.1016/S1470-2045(13)70215-8. Epub 2013 Jun 6.
4
Optimizing approaches to head and neck cancer. Metastatic head and neck cancer: new options.优化头颈癌治疗方法。转移性头颈癌：新的选择。
Ann Oncol. 2008 Sep;19 Suppl 7:vii200-3. doi: 10.1093/annonc/mdn456.
5
Combination therapy with bevacizumab and temsirolimus in squamous cell carcinoma of the head and neck.贝伐单抗与替西罗莫司联合治疗头颈部鳞状细胞癌。
Oral Oncol. 2013 Aug;49(8):e25. doi: 10.1016/j.oraloncology.2013.04.001. Epub 2013 Apr 28.
6
Cisplatin and fluorouracil with or without panitumumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck (SPECTRUM): an open-label phase 3 randomised trial.顺铂和氟尿嘧啶联合或不联合帕尼单抗治疗复发性或转移性头颈部鳞状细胞癌（SPECTRUM）：一项开放标签的 3 期随机试验。
Lancet Oncol. 2013 Jul;14(8):697-710. doi: 10.1016/S1470-2045(13)70181-5. Epub 2013 Jun 6.
7
[A combination of radiotherapy and chemotherapy with platidiam and fluorouracil in patients with head and neck cancer].[头颈部癌患者采用铂类和氟尿嘧啶联合放疗与化疗]
Lik Sprava. 1996 Mar-Apr(3-4):153-7.
8
EGFR inhibition for recurrent or metastatic HNSCC.表皮生长因子受体（EGFR）抑制用于复发性或转移性头颈部鳞状细胞癌。
Lancet Oncol. 2015 May;16(5):488-9. doi: 10.1016/S1470-2045(15)70178-6. Epub 2015 Apr 16.
9
Head and neck cancer: second-line afatinib shows promise.头颈癌：二线阿法替尼显示出前景。
Nat Rev Clin Oncol. 2015 Jul;12(7):373. doi: 10.1038/nrclinonc.2015.86. Epub 2015 May 5.
10
Hyperthermia as an adjuvant to radiation- and/or chemotherapy in far advanced recurrences of the head and neck region.热疗作为头颈部晚期复发肿瘤放疗和/或化疗的辅助治疗手段。
Strahlenther Onkol. 1987 Jul;163(7):449-52.
引用本文的文献
1
A Review of HPV-Related Head and Neck Cancer.人乳头瘤病毒相关头颈癌综述
J Clin Med. 2018 Aug 27;7(9):241. doi: 10.3390/jcm7090241.
2
Treatment de-escalation for HPV-driven oropharyngeal cancer: Where do we stand?人乳头瘤病毒（HPV）驱动的口咽癌治疗降阶梯：我们目前的状况如何？
Clin Transl Radiat Oncol. 2017 Nov 4;8:4-11. doi: 10.1016/j.ctro.2017.10.005. eCollection 2018 Jan.
Zotero 插件